pirfenidone has been researched along with Vascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Margolin, SB; Metcalfe, MS; Nicholson, ML; Toomey, D; Waller, JR | 1 |
1 other study(ies) available for pirfenidone and Vascular Diseases
| Article | Year |
|---|---|
Pirfenidone inhibits early neointimal proliferation following arterial injury.
Topics: Animal Feed; Animals; Cell Division; Dietary Supplements; Hyperplasia; Male; Muscle, Smooth, Vascular; Postoperative Complications; Pyridones; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tunica Intima; Vascular Diseases | 2002 |